We are live on
!
Find out more
FAF
Fjarde Ap-fonden Portfolio holdings
AUM
$20.9B
1-Year Est. Return
36.93%
This Fund
S&P 500
This Quarter
Est. Return
+2.06%
1 Year Est. Return
+36.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.35B
AUM Growth
-$265M
(-5.7%)
Cap. Flow
-$308M
Cap. Flow
% of AUM
-7.08%
Top 10 Holdings %
Top 10 Hldgs %
16.54%
Holding
629
New
5
Increased
18
Reduced
506
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$6.19M |
| 2 |
Medtronic
MDT
|
+$6.17M |
| 3 |
Qorvo
QRVO
|
+$3.05M |
| 4 |
Alkermes
ALKS
|
+$3M |
| 5 |
Comcast
CMCSA
|
+$2.55M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$15M |
| 2 |
Apple
AAPL
|
+$12.4M |
| 3 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$11M |
| 4 |
ExxonMobil
XOM
|
+$5.57M |
| 5 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$4.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.89% |
| 2 | Technology | 15.07% |
| 3 | Financials | 14.56% |
| 4 | Consumer Discretionary | 9.39% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Illinois Tool Works
ITW
$82.6B
| $7.92M | 0.18% |
81,080
-7,983
| -9% | -$770K |
|
127
Yum! Brands
YUM
$41.8B
| $7.88M | 0.18% |
139,186
-6,036
| -4% | -$330K |
|
128
Illumina
ILMN
$31B
| $7.88M | 0.18% |
43,607
-1,353
| -3% | -$255K |
|
129
Adobe
ADBE
$99.5B
| $7.84M | 0.18% |
106,041
-6,106
| -5% | -$455K |
|
130
Kroger
KR
$35.4B
| $7.79M | 0.18% |
203,186
-11,056
| -5% | -$395K |
|
|
ALXN
131
DELISTED
Alexion Pharmaceuticals
ALXN
| $7.75M | 0.18% |
44,716
-2,237
| -5% | -$405K |
|
|
PX
132
DELISTED
Praxair Inc
PX
| $7.68M | 0.18% |
63,647
-6,609
| -9% | -$827K |
|
133
Johnson Controls International
JCI
$88.8B
| $7.63M | 0.18% |
144,481
-8,741
| -6% | -$444K |
|
134
Air Products & Chemicals
APD
$65.7B
| $7.58M | 0.17% |
53,869
-2,318
| -4% | -$321K |
|
135
Cigna
CI
$73.7B
| $7.57M | 0.17% |
58,465
-4,606
| -7% | -$535K |
|
136
Valero Energy
VLO
$90.1B
| $7.37M | 0.17% |
115,870
-9,332
| -7% | -$521K |
|
137
Broadcom
AVGO
$1.85T
| $7.22M | 0.17% |
569,000
-29,800
| -5% | -$342K |
|
138
CSX Corp
CSX
$93.4B
| $7.22M | 0.17% |
653,832
-58,869
| -8% | -$677K |
|
139
General Mills
GIS
$19.1B
| $7.15M | 0.16% |
126,290
-19,049
| -13% | -$1.02M |
|
140
Stryker
SYK
$125B
| $7.14M | 0.16% |
77,113
-8,187
| -10% | -$762K |
|
141
Eaton
ETN
$161B
| $7.13M | 0.16% |
104,922
-9,177
| -8% | -$624K |
|
142
Norfolk Southern
NSC
$75.4B
| $7.03M | 0.16% |
68,282
-5,940
| -8% | -$635K |
|
143
Ecolab
ECL
$78.1B
| $6.92M | 0.16% |
60,317
-3,695
| -6% | -$405K |
|
144
CME Group
CME
$96.3B
| $6.89M | 0.16% |
72,732
-4,316
| -6% | -$400K |
|
145
State Street
STT
$50.6B
| $6.88M | 0.16% |
93,242
-7,277
| -7% | -$545K |
|
|
CMCSK
146
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
| $6.82M | 0.16% |
121,098
-13,048
| -10% | -$735K |
|
147
PPG Industries
PPG
$24.6B
| $6.8M | 0.16% |
60,284
-6,352
| -10% | -$728K |
|
148
Archer Daniels Midland
ADM
$38.2B
| $6.79M | 0.16% |
143,152
-10,369
| -7% | -$494K |
|
|
MRSH
149
Marsh
MRSH
$90.5B
| $6.66M | 0.15% |
118,730
-10,423
| -8% | -$588K |
|
150
Cardinal Health
CAH
$53.9B
| $6.61M | 0.15% |
72,969
-6,845
| -9% | -$589K |
|
Similar funds
MMH
VARA
SC
CB
MIC
GT
Fjarde Ap-fonden's Q1 2015 Portfolio in Review
As of Q1 2015, Fjarde Ap-fonden held 629 positions worth $4.35B, down 5.7% from $4.62B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Fjarde Ap-fonden withdrew a net $308M in Q1 2015, closing 10 positions and reducing 506 holdings. Its most notable exit was Allergan Inc, an estimated $15M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
Against the trend, Fjarde Ap-fonden opened a new position in Qorvo worth $3.42M.
- Fjarde Ap-fonden's largest Q1 2015 buy was Qorvo: 42,872 shares worth $3.42M.
- Fjarde Ap-fonden added most to Allergan plc in Q1 2015, an estimated $6.19M increase.
- Fjarde Ap-fonden's biggest Q1 2015 reduction was Apple, cutting an estimated $12.4M.
- Fjarde Ap-fonden fully exited Allergan Inc in Q1 2015, selling an estimated $15M.
- Fjarde Ap-fonden's ten largest holdings make up 17% of its $4.35B portfolio in Q1 2015.
- Fjarde Ap-fonden opened 5 new positions and closed 10 in Q1 2015.
- Fjarde Ap-fonden's portfolio value fell 5.7% quarter-over-quarter to $4.35B.
Based on Fjarde Ap-fonden's 13F filing for Q1 2015, filed 13 Apr 2015.